Official data from USPTO

BIO-COURIER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Activate monitoring for this trademark Talk to an expert

Quick snapshot

BIO-COURIER

ST13

US500000097187427

Class

1, 5

Filing

97187427

Registration

7430532

View on USPTO

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

Latest update

06/25/2024

Trademark type

Word

Nice classes

1, 5

Filing date

12/23/2021

Registration date

06/25/2024

Expiration date

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/25/2024

Last transaction

06/25/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Supplemental Register

Filing basis

Intent to use

Drawing code

Owner type

Owner location

GUILDFORD, Surrey, GB

Examiner

SORIANO, JASMINE

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

SISAF Ltd

Representatives

Evi Christou BANNER & WITCOFF, LTD.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Nanoparticle substances and nanoparticles for use in industryscience and research; Siliconsilicon for use in industryscience and research in the nature of biochemical catalysts; Siliconsilicon nanoparticle materials for use in industryscience and research; Siliconporous silicon nanoparticle materials for use in industryscience and research; lipid nanoparticles for use in industryscience and research; Siliconsilicon-lipid nanoparticles for use in industryscience and research; Siliconsilicon-stabilised hybrid lipid nanoparticles for use in industryscience and research; Siliconsilicon-stabilised lipid nanoparticles for use in industryscience and research; stabilised lipid nanoparticles for use in industryscience and research; materials being silicon for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; materials being silicon for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon-lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon-lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon-lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; materials for stabilising of chemicalbiochemical and biological substances; nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconsilicon nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconporous silicon nanoparticle materials for stabilising of chemicalbiochemical and biological substances; lipid nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconsilicon-lipid nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconsilicon-stabilised hybrid lipid nanoparticles for stabilising of chemicalbiochemical and biological substances; Siliconsilicon-stabilised lipid nanoparticles for stabilising of chemicalbiochemical and biological substances; stabilised lipid nanoparticles for stabilising of chemicalbiochemical and biological substances; materials for stabilising nucleic acids; nanoparticle materials for stabilising nucleic acids; Siliconsilicon nanoparticle materials for stabilising nucleic acids; Siliconporous silicon nanoparticle materials for stabilising nucleic acids; lipid nanoparticle materials for stabilising nucleic acids; Siliconsilicon-lipid nanoparticle materials for stabilising nucleic acids; Siliconsilicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acids; Siliconsilicon-stabilised lipid nanoparticles for stabilising nucleic acids; stabilised lipid nanoparticles for stabilising nucleic acids; materials for stabilising nucleic acid-lipid complexes; nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconsilicon nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconporous silicon nanoparticle materials for stabilising of nucleic acid-lipid complexes; lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconsilicon-lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconsilicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexes; Siliconsilicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes; stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes; all of the foregoing other than for medical or veterinary purposes and excluding use in the agricultural industry

Class 5

Nanoparticle substances and nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; silicon nanoparticle substances and silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; silicon-lipid nanoparticle substances and silicon-lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; silicon-stabilised hybrid lipid nanoparticles for medicalveterinary and nanoparticle substances and nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; silicon nanoparticle substances and silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; porous silicon nanoparticle substances and porous silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; silicon-lipid nanoparticle substances and silicon-lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; nanoparticle substances and nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; silicon nanoparticle substances and silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; silicon-lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; silicon-stabilised hybrid lipid nanoparticles for medicalveterinary and pharmaceutical treatment purposes; silicon-stabilised lipid nanoparticles for medicalveterinary and pharmaceutical treatment purposes; stabilised lipid nanoparticles for medicalveterinary and pharmaceutical treatment purposes; materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; all of the foregoing excluding use in the agricultural industry

Publications

History of USPTO decisions and trademark events.

21 publications found

NRCS

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/25/2024

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

06/25/2024

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

05/22/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/11/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/11/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/11/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

01/15/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

01/15/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/16/2023

GNFR

FINAL REFUSAL E-MAILED

10/16/2023

CNFR

FINAL REFUSAL WRITTEN

10/16/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/05/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/05/2023

ALIE

ASSIGNED TO LIE

09/05/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/20/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/27/2022

GNRT

NON-FINAL ACTION E-MAILED

10/27/2022

CNRT

NON-FINAL ACTION WRITTEN

10/27/2022

DOCK

ASSIGNED TO EXAMINER

09/27/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/30/2021

NWAP

NEW APPLICATION ENTERED

12/27/2021

Continuous trademark protection

Get notified about every new filing that threatens BIO-COURIER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.

Activate watch Consult specialist